$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000117992913000005 Filed on October 30, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$1.706B	$1.687B	$1.540B
YoY Change	8.09%	9.54%	30.88%
Cost Of Revenue	$1.457B	$1.423B	$1.357B
YoY Change	10.45%	4.89%	36.56%
Gross Profit	$249.0M	$263.8M	$183.2M
YoY Change	-3.9%	44.0%	0.11%
Gross Profit Margin	14.6%	15.64%	11.89%
Selling, General & Admin	$231.4M	$220.0M	$164.9M
YoY Change	21.09%	33.41%	21.25%
% of Gross Profit	92.93%	83.4%	90.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$25.90M	$24.13M	$20.28M
YoY Change	26.34%	18.98%	13.85%
% of Gross Profit	10.4%	9.15%	11.07%
Operating Expenses	$251.7M	$238.9M	$180.8M
YoY Change	21.42%	32.13%	20.94%
Operating Profit	-$2.700M	$24.93M	$2.368M
YoY Change	-104.99%	952.62%	-92.95%
Interest Expense	-$13.80M	$13.53M	$4.315M
YoY Change	220.93%	213.6%	-1.48%
% of Operating Profit		54.29%	182.22%
Other Income/Expense, Net	$0.00	-$13.51M	-$4.499M
YoY Change	-100.0%	200.24%
Pretax Income	-$16.50M	$11.42M	-$2.131M
YoY Change	-132.9%	-635.8%	-107.3%
Income Tax	-$7.500M	$3.865M	-$1.966M
% Of Pretax Income		33.85%
Net Earnings	-$9.126M	$7.569M	$3.364M
YoY Change	-135.59%	125.0%	-82.25%
Net Earnings / Revenue	-0.54%	0.45%	0.22%
Basic Earnings Per Share	-$0.20	$0.17	$0.07
Diluted Earnings Per Share	-$0.20	$0.16	$0.07
COMMON SHARES
Basic Shares Outstanding	45.76M shares	45.70M shares	46.55M shares
Diluted Shares Outstanding		47.06M shares	46.88M shares

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.639B	$1.592B	$1.072B
YoY Change	43.94%	48.42%	32.0%
Cash & Equivalents	$936.0M	$856.6M	$715.5M
Short-Term Investments	$703.1M	$735.2M	$356.9M
Other Short-Term Assets	$42.48M	$50.06M	$30.00M
YoY Change	49.67%	66.86%	-17.58%
Inventory
Prepaid Expenses
Receivables	$298.9M	$294.0M	$156.9M
Other Receivables	$32.80M	$0.00	$33.50M
Total Short-Term Assets	$2.040B	$1.966B	$1.314B
YoY Change	51.18%	49.6%	27.04%
LONG-TERM ASSETS
Property, Plant & Equipment	$292.1M	$267.3M	$211.0M
YoY Change	31.9%	26.69%	65.21%
Goodwill	$230.7M	$230.8M	$151.1M
YoY Change	52.72%	52.75%
Intangibles
YoY Change
Long-Term Investments	$10.90M	$11.70M	$13.50M
YoY Change	-18.66%	-13.33%	-25.41%
Other Assets	$46.46M	$35.74M	$20.10M
YoY Change	136.8%	77.81%	-82.87%
Total Long-Term Assets	$948.3M	$958.9M	$592.7M
YoY Change	61.92%	61.77%	1.54%
TOTAL ASSETS
Total Short-Term Assets	$2.040B	$1.966B	$1.314B
Total Long-Term Assets	$948.3M	$958.9M	$592.7M
Total Assets	$2.988B	$2.925B	$1.907B
YoY Change	54.43%	53.38%	17.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$320.0M	$282.7M	$151.0M
YoY Change	73.91%	87.22%	6.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$182.0M	$109.0K	$1.143M
YoY Change	15658.27%	-90.46%
Total Short-Term Liabilities	$1.294B	$1.045B	$831.9M
YoY Change	56.27%	25.66%	37.65%
LONG-TERM LIABILITIES
Long-Term Debt	$602.9M	$770.1M	$260.6M
YoY Change	130.3%	195.57%	55.0%
Other Long-Term Liabilities	$26.35M	$25.15M	$22.10M
YoY Change	12.23%	13.8%	-46.1%
Total Long-Term Liabilities	$26.35M	$25.15M	$282.7M
YoY Change	-90.76%	-91.1%	35.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.294B	$1.045B	$831.9M
Total Long-Term Liabilities	$26.35M	$25.15M	$282.7M
Total Liabilities	$2.110B	$2.032B	$1.152B
YoY Change	83.08%	76.4%	37.72%
SHAREHOLDERS EQUITY
Retained Earnings	$553.1M	$562.3M	$474.6M
YoY Change	10.58%	18.48%
Common Stock	$340.8M	$332.0M	$280.7M
YoY Change	19.38%	18.25%	7.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$0.00	$0.00
YoY Change	-100.0%
Treasury Stock Shares		0.000 shares
Shareholders Equity	$892.9M	$892.8M	$755.0M
YoY Change
Total Liabilities & Shareholders Equity	$3.003B	$2.925B	$1.907B
YoY Change	55.2%	53.38%	17.84%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$9.126M	$7.569M	$3.364M
YoY Change	-135.59%	125.0%	-82.25%
Depreciation, Depletion And Amortization	$25.90M	$24.13M	$20.28M
YoY Change	26.34%	18.98%	13.85%
Cash From Operating Activities	$78.40M	$223.4M	$28.00M
YoY Change	-6.44%	697.86%	-30.52%
INVESTING ACTIVITIES
Capital Expenditures	-$33.60M	-$29.20M	-$19.20M
YoY Change	31.25%	52.08%	28.0%
Acquisitions
YoY Change
Other Investing Activities	$31.70M	-$80.40M	-$10.20M
YoY Change	39.04%	688.24%	-191.07%
Cash From Investing Activities	-$1.900M	-$109.6M	-$29.50M
YoY Change	-32.14%	271.53%	656.41%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$50.00M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.900M	0.000	-10.20M
YoY Change	-514.29%	-100.0%	25.93%
NET CHANGE
Cash From Operating Activities	78.40M	223.4M	28.00M
Cash From Investing Activities	-1.900M	-109.6M	-29.50M
Cash From Financing Activities	2.900M	0.000	-10.20M
Net Change In Cash	79.40M	113.8M	-11.70M
YoY Change	-1.12%	-1072.65%	-141.34%
FREE CASH FLOW
Cash From Operating Activities	$78.40M	$223.4M	$28.00M
Capital Expenditures	-$33.60M	-$29.20M	-$19.20M
Free Cash Flow	$112.0M	$252.6M	$47.20M
YoY Change	2.38%	435.17%	-14.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1411000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	285524000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	331958000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	184034000	USD
CY2013Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	282727000	USD
CY2012Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6520000	USD
CY2013Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5508000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-457000	USD
CY2013Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	79000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	79000000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15448000	USD
CY2012Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5636000	USD
CY2013Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8504000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20654000	USD
CY2012Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1499000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4414000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15747000	USD
CY2013Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6059000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3042000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	825000	USD
CY2013Q3	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	601100000	USD
CY2012Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	549700000	USD
CY2013Q3	us-gaap	Assets Assets	2925066000	USD
CY2012Q4	us-gaap	Assets Assets	1934822000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	1349126000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	1966215000	USD
CY2013Q3	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	11674000	USD
CY2012Q4	us-gaap	Auction Rate Securities Noncurrent AuctionRateSecuritiesNoncurrent	13419000	USD
CY2012Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	357000000	USD
CY2013Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	749100000	USD
CY2012Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	356264000	USD
CY2013Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	746825000	USD
CY2013Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	351952000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	89195000	USD
CY2013Q3	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	29678000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	13419000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	330370000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	328809000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	12400000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	11674000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAmortizedCost	749100000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	406330000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	406342000	USD
CY2013Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	746825000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	795770000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	856556000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	715480000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	493827000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	221653000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	60786000	USD
CY2013Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	53.8475
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	19222000	USD
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	175468000	USD
CY2013Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	591884000	USD
CY2013Q3	us-gaap	Costs And Expenses CostsAndExpenses	1662153000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4744067000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	4346999000	USD
CY2012Q3	us-gaap	Costs And Expenses CostsAndExpenses	1537782000	USD
CY2012Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	58313000	USD
CY2013Q3	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	48768000	USD
CY2013Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46762000	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	45757000	shares
CY2013Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	46000	USD
CY2012Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	47000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14778000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8863000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3819000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	61101000	USD
	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2013Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	591884000	USD
CY2013Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	737000000	USD
CY2013Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2013-02-15
CY2013Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	145116000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	141798000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	124388000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2013Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	3090000	USD
CY2013Q3	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	30480000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	32443000	USD
CY2013Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2012Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	37900000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	46916000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	52449000	USD
CY2012Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15858000	USD
CY2013Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	18871000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58289000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68035000	USD
CY2013Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24128000	USD
CY2012Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20279000	USD
CY2013Q3	us-gaap	Derivative Assets DerivativeAssets	191663000	USD
CY2012Q4	us-gaap	Derivative Assets DerivativeAssets	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-1270000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-3383000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-1270000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-3383000	USD
CY2012Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1307000	USD
CY2013Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	191556000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	10046000	USD
	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	4115000	USD
CY2013Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-97000	USD
CY2012Q3	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	-1474000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2013Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2012Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.36
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.33
CY2012Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2013Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y8M18D
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	0	USD
	us-gaap	Escrow Deposit Disbursements Related To Property Acquisition1 EscrowDepositDisbursementsRelatedToPropertyAcquisition1	-332000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	1238000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	3698000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	72000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	159000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	1059000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	397000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	1635000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Other Comprehensive Income Loss FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss	505000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Issues FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetIssues	-75074000	USD
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	4350000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements	-76747000	USD
CY2011Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	16134000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	13419000	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	-47732000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-3382000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	59947000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	121845000	USD
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2012Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	77711000	USD
CY2013Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	104635000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1747000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	1747000	USD
	us-gaap	Gain Or Loss On Sale Of Stock In Subsidiary GainOrLossOnSaleOfStockInSubsidiary	0	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	176233000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	365564000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	127035000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	478990000	USD
CY2013Q3	us-gaap	Goodwill Goodwill	230783000	USD
CY2012Q4	us-gaap	Goodwill Goodwill	151088000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	127606000	USD
	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	120953000	USD
CY2012Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	37894000	USD
CY2013Q3	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	43723000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4583818000	USD
	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	4066737000	USD
CY2013Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1584656000	USD
CY2012Q3	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	1448600000	USD
CY2013Q3	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	65225000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5596000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	5592000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	59636000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	59633000	USD
CY2013Q3	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	65232000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-165000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	53871000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7553000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-13328000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	11418000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2131000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	97662000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-24441000	USD
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.18
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.29
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.17
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.15
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.29
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0.16
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	3529000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-2525000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	8184000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	16000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.18
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.08
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.05
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.18
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.08
	us-gaap	Interest Expense Debt InterestExpenseDebt	9673000	USD
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	4884000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.05
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1966000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43791000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11113000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3865000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	72156000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1074000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-9030000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	20991000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1012000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-21878000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	38442000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-523000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	92354000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-17410000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	133987000	USD
	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	138176000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	7574000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	4775000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10574000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	27552000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	144285000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-10989000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	21124000	USD
	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	3034000	USD
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	910000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	527000	shares
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	453000	shares
CY2012Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	334000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	532000	shares
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3893000	USD
CY2012Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1155000	USD
CY2013Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	1740000	USD
	us-gaap	Interest Expense InterestExpense	38236000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	13532000	USD
CY2012Q3	us-gaap	Interest Expense InterestExpense	4315000	USD
	us-gaap	Interest Expense InterestExpense	12421000	USD
CY2013Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	9359000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	24874000	USD
CY2012Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3252000	USD
CY2012Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1753000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5259000	USD
CY2013Q3	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3300000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	9127000	USD
	us-gaap	Interest Paid InterestPaid	28035000	USD
	us-gaap	Interest Paid InterestPaid	5663000	USD
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-8053000	USD
	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	-5166000	USD
CY2012Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	10300000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	1152508000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	2032218000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1934822000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2925066000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	59947000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	0	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	828037000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1045438000	USD
CY2013Q3	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	632706000	USD
CY2012Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	494530000	USD
CY2012Q4	us-gaap	Line Of Credit Facility Amount Outstanding LineOfCreditFacilityAmountOutstanding	40000000	USD
CY2013Q3	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	170000000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	24926000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	2368000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10750000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	139245000	USD
CY2012Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	4079000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2013Q3	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	490458000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-541416000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90794000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	264024000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	111744000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	3364000	USD
	us-gaap	Net Income Loss NetIncomeLoss	62055000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	7569000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15853000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	28386000	USD
CY2013Q3	us-gaap	Long Term Debt LongTermDebt	737000000	USD
CY2013Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	109000	USD
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1155000	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	550000000	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	187000000	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2013Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	0	USD
CY2013Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	735151000	USD
CY2012Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	342845000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions MinimumLeasePaymentsSaleLeasebackTransactions	476995000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Remainder Of Fiscal Year MinimumLeasePaymentsSaleLeasebackTransactionsRemainderOfFiscalYear	3300000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Thereafter MinimumLeasePaymentsSaleLeasebackTransactionsThereafter	385813000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Five Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears	20137000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Four Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears	19496000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within One Year MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear	14395000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Three Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears	18877000	USD
CY2013Q3	us-gaap	Minimum Lease Payments Sale Leaseback Transactions Within Two Years MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears	18277000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48423000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	16476000	USD
CY2013Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5860000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	12315000	USD
CY2013Q3	us-gaap	Other Assets Current OtherAssetsCurrent	50061000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19621000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35736000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1294000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-954000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	455000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1075000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	733000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	1734000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2087000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-1539000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-585000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	659000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	793000	USD
CY2012Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	278000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	23480000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25152000	USD
CY2012Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	86316000	USD
CY2013Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	0	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1270000	USD
CY2012Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	184000	USD
CY2013Q3	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	-24000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	3347000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13691000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-41583000	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4499000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13508000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	149331000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2013Q3	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	50000000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	57684000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	52548000	USD
	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	64426000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	234465000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	627953000	USD
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	18799000	USD
	us-gaap	Payments To Acquire Projects PaymentsToAcquireProjects	-9545000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3965834000	USD
CY2013Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1383213000	USD
CY2012Q3	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	1319991000	USD
	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3715455000	USD
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2013Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	0	USD
	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	9162000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	537973000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5571000	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	5156000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	75074000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	60000000	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	149300000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	213665000	USD
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	227800000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	221443000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	267277000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	250000	USD
CY2012Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	12000	USD
CY2013Q3	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	27000	USD
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	169000	USD
CY2013Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	293967000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	149682000	USD
CY2013Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	40000000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	47471000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	846000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	40000000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	20000000	USD
CY2013Q3	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	472100000	USD
CY2012Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	46900000	USD
CY2013Q3	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	65225000	USD
CY2012Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	44101000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	562255000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	500200000	USD
	us-gaap	Revenues Revenues	4883312000	USD
CY2013Q3	us-gaap	Revenues Revenues	1687079000	USD
CY2012Q3	us-gaap	Revenues Revenues	1540150000	USD
	us-gaap	Revenues Revenues	4336249000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	158694000	USD
	us-gaap	Sale Leaseback Transaction Gross Proceeds SaleLeasebackTransactionGrossProceeds	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	15448000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	20654000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	31500	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	25.55
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	986577	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1417628	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	23.74
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	29.06
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	581329	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	24300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	19300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	24.72
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	333761000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	300000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	45000000	shares
CY2012	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.97
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.02
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4495000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	414061000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	388761000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	4495000	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	388761000	shares
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	4371000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y8M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y7M
CY2011Q4	us-gaap	Shares Outstanding SharesOutstanding	45815000	shares
CY2012Q2	us-gaap	Shares Outstanding SharesOutstanding	46527000	shares
CY2012Q4	us-gaap	Shares Outstanding SharesOutstanding	46762000	shares
CY2013Q2	us-gaap	Shares Outstanding SharesOutstanding	45683000	shares
CY2013Q3	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	10700000	USD
CY2013Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	637000000	USD
CY2013Q3	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	362200000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	8600000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7400000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46767000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46301000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46880000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	50000000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10600000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12500000	USD
CY2012Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	56000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	67000	USD
	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	620000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	70000000	shares
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	19100000	USD
CY2013Q1	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	75000000	USD
CY2013Q3	us-gaap	Stock Repurchase Program Authorized Amount StockRepurchaseProgramAuthorizedAmount	50000000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	9852000	USD
	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	6667000	USD
CY2013Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1624959	shares
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	892848000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	782314000	USD
	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	110500000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	3882000	USD
	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	0	USD
CY2012Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	37004000	USD
CY2013Q3	us-gaap	Technology Services Costs TechnologyServicesCosts	40113000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	119188000	USD
	us-gaap	Technology Services Costs TechnologyServicesCosts	98111000	USD
CY2012Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	48422000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	150528000	USD
	us-gaap	Technology Services Revenue TechnologyServicesRevenue	132351000	USD
CY2013Q3	us-gaap	Technology Services Revenue TechnologyServicesRevenue	51100000	USD
CY2013Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2012Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	111000	shares
CY2013Q3	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2012Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3000000	USD
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47062000	shares
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	1375000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	0	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	486000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	16000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	19000	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	321000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45708000	shares
CY2012Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46546000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45699000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46301000	shares
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	16128000	USD
	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	4414000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	38647000	USD
	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	52483000	USD
CY2013Q3	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	17538000	USD
CY2012Q3	moh	Amount Of Current Year Quality Incentive Premium Revenue Recognized AmountOfCurrentYearQualityIncentivePremiumRevenueRecognized	12397000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	2116000	USD
	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	7759000	USD
CY2013Q3	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	-50000	USD
CY2012Q3	moh	Amount Of Quality Incentive Premium Revenue Recognized From Prior Year AmountOfQualityIncentivePremiumRevenueRecognizedFromPriorYear	246000	USD
CY2013Q3	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	18400000	USD
CY2012Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	300000	USD
CY2013Q3	moh	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments	942000	USD
CY2012Q4	moh	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAggregateLossesAccumulatedInInvestments	1231000	USD
CY2013Q3	moh	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	1836000	USD
CY2012Q4	moh	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Aggregate Losses Accumulated In Investments AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAggregateLossesAccumulatedInInvestments	314000	USD
CY2012Q4	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	809000	USD
CY2013Q3	moh	Available For Sale Securities Gross Unrealized Gain Accumulated In Investments AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments	503000	USD
CY2013Q3	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	195	Security
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Less Than Twelve Months Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionLessThanTwelveMonthsQualitativeDisclosureNumberOfPositions	72	Security
CY2013Q3	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	51	Security
CY2012Q4	moh	Available For Sale Securities In Unrealized Loss Position Twelve Months Or More Qualitative Disclosure Number Of Positions AvailableForSaleSecuritiesInUnrealizedLossPositionTwelveMonthsOrMoreQualitativeDisclosureNumberOfPositions	21	Security
CY2013Q3	moh	Availableforsale Securities Gross Unrealized Loss Accumulated In Investments AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	2778000	USD
CY2012Q4	moh	Availableforsale Securities Gross Unrealized Loss Accumulated In Investments AvailableforsaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments	1545000	USD
CY2013Q3	moh	Benefit From Prior Period Claims Development BenefitFromPriorPeriodClaimsDevelopment	54000000	USD
CY2013Q3	moh	Call Spread Cash Paid CallSpreadCashPaid	74200000	USD
	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2012	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	5136055000	USD
CY2013Q3	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	1415670000	USD
	moh	Current Year Components Of Incurred Medical Care Costs CurrentYearComponentsOfIncurredMedicalCareCosts	4021461000	USD
	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	3410689000	USD
CY2013Q3	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	851025000	USD
CY2012	moh	Current Year Payments For Medical Care Costs CurrentYearPaymentsForMedicalCareCosts	4649363000	USD
CY2012Q3	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	46546000	shares
	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	46301000	shares
CY2013Q3	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45699000	shares
	moh	Denominator For Basic Earnings Per Share DenominatorForBasicEarningsPerShare	45708000	shares
	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46767000	shares
	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46301000	shares
CY2012Q3	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	46880000	shares
CY2013Q3	moh	Denominator For Diluted Earnings Per Share DenominatorForDilutedEarningsPerShare	47062000	shares
	moh	Derivative Losson Derivative Warrants DerivativeLossonDerivativeWarrants	3900000	USD
	moh	Derivative Settlement Amount DerivativeSettlementAmount	875000	USD
	moh	Derivative Settlement Amount DerivativeSettlementAmount	0	USD
CY2013Q2	moh	Derivative Settlement Amount DerivativeSettlementAmount	900000	USD
	moh	Discontinued Operation Tax Expense Benefitfrom Stock Abandon DiscontinuedOperationTaxExpenseBenefitfromStockAbandon	9500000	USD
	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	30942000	USD
	moh	Divestiture Of Business Decrease In Carrying Value Of Assets DivestitureOfBusinessDecreaseInCarryingValueOfAssets	0	USD
	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	0	USD
	moh	Divestiture Of Business Decrease In Carrying Value Of Liabilities DivestitureOfBusinessDecreaseInCarryingValueOfLiabilities	23527000	USD
CY2012Q4	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	228799000	USD
CY2013Q3	moh	Goodwill And Intangible Assets Net GoodwillAndIntangibleAssetsNet	335418000	USD
	moh	Health Care Organization Estimated Assessment Fees HealthCareOrganizationEstimatedAssessmentFees	100000000	USD
CY2012Q4	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	127098000	USD
CY2013Q3	moh	Health Plans Segment Receivables HealthPlansSegmentReceivables	276548000	USD
CY2012Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	0	USD
CY2013Q3	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	178188000	USD
CY2012Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	494530000	USD
CY2013Q1	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	465487000	USD
CY2012	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	5096760000	USD
	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	3967421000	USD
CY2013Q3	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	8200000	USD
CY2012Q3	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	7000000	USD
	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	24600000	USD
CY2011	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.098
CY2011Q4	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.098
	moh	Premium Tax Expenses PremiumTaxExpenses	127606000	USD
CY2012Q3	moh	Premium Tax Expenses PremiumTaxExpenses	37894000	USD
CY2013Q3	moh	Premium Tax Expenses PremiumTaxExpenses	43723000	USD
CY2013Q3	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	632706000	USD
CY2011Q4	moh	Liability For Claims And Claims Adjustment Expense Health LiabilityForClaimsAndClaimsAdjustmentExpenseHealth	402476000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	52869000	USD
	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	62050000	USD
CY2013Q3	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	20939000	USD
CY2012Q3	moh	Maximum Available Quality Incentive Premium Current Year MaximumAvailableQualityIncentivePremiumCurrentYear	21488000	USD
	moh	Maximum Contract Term MaximumContractTerm	P4Y
CY2013Q3	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	64100000	USD
CY2013Q3	moh	Medical Claimsand Benefits Receivables MedicalClaimsandBenefitsReceivables	69700000	USD
	moh	Medicare Revenue Risk Adjustment Maximum Periodfrom Yearof Service MedicareRevenueRiskAdjustmentMaximumPeriodfromYearofService	P2Y
	moh	Minimum Contract Term MinimumContractTerm	P3Y
	moh	Number Of Categories For Component Of Premium Revenue NumberOfCategoriesForComponentOfPremiumRevenue	2	category
CY2013Q3	moh	Number Of Members Eligible For Health Care Programs NumberOfMembersEligibleForHealthCarePrograms	1900000	Customer
	moh	Numberof Renewal Options NumberofRenewalOptions	5	Option
	moh	Par Value Of Auction Rate Securities Sold ParValueOfAuctionRateSecuritiesSold	12400000	USD
	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	3829245000	USD
CY2012	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	5004706000	USD
CY2013Q3	moh	Payments For Medical Care Costs PaymentsForMedicalCareCosts	1215876000	USD
	moh	Payments For Medical Services Fees To Related Party PaymentsForMedicalServicesFeesToRelatedParty	20600000	USD
CY2012	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.109
CY2013Q2	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.070
CY2013Q3	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.006
CY2012	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.008
	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.010
	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.009
CY2012	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.007
CY2013Q3	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.005
CY2013Q3	moh	Policyholder Benefitsand Claims Incurred Net Health Continuingand Discontinued Operations PolicyholderBenefitsandClaimsIncurredNetHealthContinuingandDiscontinuedOperations	1383095000	USD
	moh	Premium Tax Expenses PremiumTaxExpenses	120953000	USD
	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-37700000	USD
CY2012	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-39295000	USD
CY2013Q3	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-32575000	USD
	moh	Prior Year Components Of Incurred Medical Care Costs PriorYearComponentsOfIncurredMedicalCareCosts	-54040000	USD
	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	418556000	USD
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue	24.04
CY2013Q3	moh	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Plans SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPlans	2	Plan
CY2013Q1	moh	Stock Repurchase Program Average Price Per Share StockRepurchaseProgramAveragePricePerShare	30.77
CY2012Q4	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	8400000	USD
CY2013Q3	moh	Unrecognized Tax Benefits State Refund Claims UnrecognizedTaxBenefitsStateRefundClaims	10500000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	45760400	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
	dei	Trading Symbol TradingSymbol	moh
CY2013Q3	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	364851000	USD
CY2012	moh	Prior Year Payments For Medical Care Costs PriorYearPaymentsForMedicalCareCosts	355343000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	60242000	USD
	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	40763000	USD
CY2012Q3	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	12643000	USD
CY2013Q3	moh	Quality Incentive Premium Revenue Recognized QualityIncentivePremiumRevenueRecognized	17488000	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	0	USD
	moh	Retirement Of Treasury Stock RetirementOfTreasuryStock	53000000	USD
	moh	Sale Leaseback Transaction Termof Lease SaleLeasebackTransactionTermofLease	P25Y
	moh	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Pair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodPairValue	33300000	USD
	moh	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Granted In Period Pair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodPairValue	23000000	USD
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingIntrinsicValue		USD
CY2013Q3	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageGrantDateFairValue	22.50
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	20.11
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue	17.63
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodIntrinsicValue		USD
	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue		USD
CY2012Q4	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	22.39
CY2013Q3	moh	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageFairValue	24.04

Files In Submission

Name	View Source	Status
0001179929-13-000005-index-headers.html	Edgar Link	pending
0001179929-13-000005-index.html	Edgar Link	pending
0001179929-13-000005.txt	Edgar Link	pending
0001179929-13-000005-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
moh-20130930.xml	Edgar Link	completed
moh-20130930.xsd	Edgar Link	pending
moh-20130930x10q.htm	Edgar Link	pending
moh-20130930_cal.xml	Edgar Link	unprocessable
moh-20130930_def.xml	Edgar Link	unprocessable
moh-20130930_lab.xml	Edgar Link	unprocessable
moh-20130930_pre.xml	Edgar Link	unprocessable
moh-2013x09x30xex101.htm	Edgar Link	pending
moh-2013x09x30xex311.htm	Edgar Link	pending
moh-2013x09x30xex312.htm	Edgar Link	pending
moh-2013x09x30xex321.htm	Edgar Link	pending
moh-2013x09x30xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-Q Financial Statement

#000117992913000005 Filed on October 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2013 Q4 Form 10-Q Financial Statement

#000117992913000005 Filed on October 30, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh